EP2228055A1 — Riluzole liquid emulsions
Assigned to Italfarmaco SpA · Expires 2010-09-15 · 16y expired
What this patent protects
Physically and chemically stable liquid O/W and W/O emulsions of riluzole are disclosed, together with methods for the preparation thereof. Such emulsions contain riluzole or a pharmaceutically acceptable salt or derivative thereof in amounts from about 0.1 % to about 20 % w/w, p…
USPTO Abstract
Physically and chemically stable liquid O/W and W/O emulsions of riluzole are disclosed, together with methods for the preparation thereof. Such emulsions contain riluzole or a pharmaceutically acceptable salt or derivative thereof in amounts from about 0.1 % to about 20 % w/w, preferably from about 0.5% to about 5% w/w; such emulsions are devoided of the known local (mouth) anaesthetic effects of riluzole.
Drugs covered by this patent
- Rilutek (RILUZOLE) · Covis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.